Provided by Tiger Trade Technology Pte. Ltd.

Warren Buffett holdings

3,184.35
+24.640.78%
Number of Gainers:22
Number of Losers:13
Number of Flat:- -
PE:- -
High:3,191.24
Open:3,159.88
Low:3,159.53
Close:3,159.71
Volume:295.92M
Turnover:37.73B
Market Cap:11.33T
Float Cap:10.77T

Loading ...

Bristol Myers reports results from prespecified analysis of EXCALIBER-RRMM trial

TIPRANKS
·
Sep 25

Nvidia, Meta, Akamai, Comcast, Zscaler, Nike, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 25

Bristol Myers Squibb Wins FDA Accelerated Approval for Zenbexus Combo in Multiple Myeloma

Reuters
·
Sep 25

iHeartMedia Rings in the Holiday Season with the Iconic 2026 National ‘Iheartradio Jingle Ball Tour Presented by Capital One’

THOMSON REUTERS
·
Sep 25

Apple Stock Forecast: $5 Trillion Milestone Meets New iPhone Growth Cycle

TradingKey
·
Sep 25

Morgan Stanley is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 25

Honeywell Technologies Initiated at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 25

Insight Guru Says Verizon Valuation Implies Recovery, with VZ at 12.2x Earnings Versus AT&T at 8.2x

Reuters
·
Sep 25

Bank of America Trims Stake in Turkish Baked Goods Producer DMR

TIPRANKS
·
Sep 25

Sector Update: Consumer Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Sep 25

President of Kroger Health Colleen Lindholz Announces Retirement After 31 Years of Service

THOMSON REUTERS
·
Sep 25

Update: Amazon's Vietnamese Satellite Division Secures License for Private Telecom Network

MT Newswires Live
·
Sep 25

U-Wifi: Announces Strategic Program with T-Mobile to Expand Affordable Internet Access Nationwide

THOMSON REUTERS
·
Sep 25

Jefferies to Host Annual Investor Day with CEO Rich Handler, President Brian Friedman Speaking

Reuters
·
Sep 25

How to Keep Profiting from AI While Shielding Your Portfolio Against the Risk of a Slowdown

Dow Jones
·
Sep 25

Giant "Bless the Motherland" Floral Basket Debuts at Tiananmen Square in Beijing

Deep News
·
Sep 25

Publicis' 2027 Prospects Look Increasingly Clear

Dow Jones
·
Sep 25

Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study

TIPRANKS
·
Sep 25

J&J - Tremfya Meets Primary Endpoint for Basdai Score Improvement at Week 24

THOMSON REUTERS
·
Sep 25

Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study

THOMSON REUTERS
·
Sep 25